We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.42%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$11.6B
AUM Growth
+$243M
(+2.1%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-6.61%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
303
New
50
Increased
66
Reduced
133
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$102M |
| 2 |
S&P Global
SPGI
|
+$82.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$72.4M |
| 4 |
Nike
NKE
|
+$55.5M |
| 5 |
Avery Dennison
AVY
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$95.4M |
| 2 |
TJX Companies
TJX
|
+$94.8M |
| 3 |
Chubb
CB
|
+$87.2M |
| 4 |
Intel
INTC
|
+$80.1M |
| 5 |
Union Pacific
UNP
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.63% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
Intel
INTC
$508B
| $5.72M | 0.05% |
158,657
-2,214,783
| -93% | -$80.1M |
|
227
Kimberly-Clark
KMB
$37B
| $5.43M | 0.05% |
41,277
-150
| -0.4% | -$18.9K |
|
228
Motorola Solutions
MSI
$73.7B
| $5.36M | 0.05% |
+62,130
| New | +$5.08M |
|
229
LyondellBasell Industries
LYB
$19.7B
| $5.02M | 0.04% |
+55,080
| New | +$5.03M |
|
230
Thermo Fisher Scientific
TMO
$209B
| $4.71M | 0.04% |
30,671
-382,445
| -93% | -$58.5M |
|
231
Orion
OEC
$373M
| $4.46M | 0.04% |
217,665
-770
| -0.4% | -$15.8K |
|
232
Microchip Technology
MCHP
$43.7B
| $4.2M | 0.04% |
113,910
-330
| -0.3% | -$11.6K |
|
233
Lockheed Martin
LMT
$136B
| $3.67M | 0.03% |
13,718
-12,648
| -48% | -$3.31M |
|
234
International Paper
IP
$22.4B
| $3.25M | 0.03% |
+67,653
| New | +$3.39M |
|
|
235
Gilead Sciences
GILD
$164B
| $3.09M | 0.03% |
45,465
-1,356,514
| -97% | -$95.4M |
|
236
Baxter International
BAX
$14.3B
| $2.11M | 0.02% |
40,745
-4,610
| -10% | -$227K |
|
|
237
Chubb
CB
$134B
| $2.06M | 0.02% |
15,140
-648,446
| -98% | -$87.2M |
|
|
IPHI
238
DELISTED
INPHI CORPORATION
IPHI
| $1.8M | 0.02% |
36,930
-260,217
| -88% | -$12.2M |
|
|
LABL
239
DELISTED
Multi-Color Corp
LABL
| $1.47M | 0.01% |
20,641
-202,689
| -91% | -$15.1M |
|
|
CHMT
240
DELISTED
Chemtura Corporation
CHMT
| $1.43M | 0.01% |
42,730
| – | – |
|
241
MACOM Technology Solutions
MTSI
$20.9B
| $1.3M | 0.01% |
+27,010
| New | +$1.26M |
|
|
WCN
242
Waste Connections
WCN
$42B
| $1.29M | 0.01% |
21,938
| – | – |
|
243
Kirby Corp
KEX
$7.06B
| $1.17M | 0.01% |
16,590
| – | – |
|
244
Sabre
SABR
$830M
| $952K | 0.01% |
44,940
-2,308,477
| -98% | -$52.9M |
|
|
LGF.A
245
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $738K | 0.01% |
27,795
-925,883
| -97% | -$25.2M |
|
246
CSX Corp
CSX
$94.3B
| $698K | 0.01% |
45,000
| – | – |
|
247
SLB Ltd
SLB
$75.3B
| $658K | 0.01% |
8,424
| – | – |
|
248
SPDR Gold Trust
GLD
$132B
| $499K | ﹤0.01% |
+4,200
| New | +$488K |
|
|
PRAH
249
DELISTED
PRA Health Sciences, Inc.
PRAH
| $450K | ﹤0.01% |
+6,900
| New | +$406K |
|
|
PBNC
250
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $369K | ﹤0.01% |
+6,900
| New | +$335K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.
- Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
- Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
- Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
- Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
- Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
- Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.
Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.